Ribonucleic acid-based therapy for myocardial diseases: LncRNA C2dat1-based therapy for Cardiac repair and myocardial infarction: LncRNA C2dat1 increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 13/January/2018, 10.19 am